Neurodegenerative diseases, such as Alzheimer's disease (AD), and their associated
deterioration of cognitive function are common causes of disability. The slowly developing …

Cognitive event-related potentials (ERPs) have been used as a marker of cognitive function
in patients with psychiatric and neurological disorders. In particular, the P300 potential has …

Predicting which individuals will progress to Alzheimer's disease (AD) is important in both
clinical and research settings. We used brain Event-Related Potentials (ERPs) obtained in a …

Only a small proportion of individuals with Mild Cognitive Impairment (MCI) will convert to
dementia. Methods currently available to identify risk for conversion do not combine enough …

OBJECTIVES: The P300 is a useful psychophysiological index that reflects cognitive
functions; however, the relationship between P300 indices and neuropsychological tests in …

OBJECTIVES: Early diagnosis and monitoring of disease progression have become vital in
clinical practice as disease modifying treatments for Alzheimer's disease (AD) become …

Abstract The Alzheimer's Association's Research Roundtable met in May 2014 to explore
recent progress in developing biomarkers to improve understanding of disease …

Accurate and early diagnosis of Alzheimer's Disease (AD) with reliable and noninvasive
methods is of great importance for clinical practice as effective and specific antidementive …

Background So far, no cost-efficient, widely-used biomarkers have been established to
facilitate the objectivization of Alzheimer's disease (AD) diagnosis and monitoring. Research …

During the last century, the world population has shown a staggering increase in its
proportion of elderly members and thus neurodegenerative diseases like Alzheimer's …